EDAP TMS S.A. - AMERICAN DEPOSITARY SHARES EACH R

NetDania - New 12 months Low: EDAP TMS S.A. - AMERICAN DEPOSITARY SHARES EACH R

26 Aug 2024 11:26:36 By NetDania Notify

EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024

07 Aug 2024 07:00:00 By Nasdaq GlobeNewswire

EDAP’s Focal One Robotic HIFU Platform to be Featured at 41st World Congress of Endourology and Uro-Technology Meeting (WCET 2024)

06 Aug 2024 07:00:00 By Nasdaq GlobeNewswire

EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis

19 Jul 2024 16:15:00 By Nasdaq GlobeNewswire

EDAP Appoints Fran Schulz to Board of Directors  

08 Jul 2024 07:00:00 By Nasdaq GlobeNewswire

EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations

03 Jun 2024 08:00:00 By Nasdaq GlobeNewswire

EDAP to Present at the Jefferies Global Healthcare Conference

22 May 2024 08:00:00 By Nasdaq GlobeNewswire

EDAP Reports First Quarter 2024 Financial Results

16 May 2024 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting

06 May 2024 08:00:00 By Nasdaq GlobeNewswire

EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024

02 May 2024 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting

23 Apr 2024 08:00:00 By Nasdaq GlobeNewswire

EDAP Reports Fourth Quarter and Full-Year 2023 Financial Results

27 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024

13 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

06 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis

04 Mar 2024 07:00:00 By Nasdaq GlobeNewswire

EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues

29 Feb 2024 07:00:00 By Nasdaq GlobeNewswire

EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis

01 Feb 2024 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces Preliminary Fourth Quarter Record Focal One® System Sales and Placements

08 Jan 2024 08:00:00 By Nasdaq GlobeNewswire

EDAP Appoints Ken Mobeck, Global Chief Financial Officer, and Francois Dietsch, Global Chief Accounting Officer

02 Jan 2024 08:00:00 By Nasdaq GlobeNewswire

EDAP Announces Positive Opinion for Reimbursement from the French National Authority for Health (HAS) for HIFU treatment of Prostate Cancer

12 Dec 2023 08:00:00 By Nasdaq GlobeNewswire